Thomas L. Harrison
Known title: DirectorCIK: 0001247340
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Advanced Flower Capital Reports Q2 2026 Earnings. Advanced Flower Capital released its Q2 2026 earnings conference call transcript. The company is currently trading near the middle of its 52-week price range. Recent trading activity has shown a spike in volume, indicating increased market interest in the stock following the financial update.
Transaction History
| AGEN | ▲ Buy | Grant | 4,443 | $31K | 10/1/2026 | View on chart |
| AGEN | ▲ Buy | Grant | 8,547 | $31K | 7/1/2026 | View on chart |
| AGEN | ▲ Buy | Grant | 9,228 | $31K | 4/1/2026 | View on chart |
| AGEN | ▲ Buy | Grant | 7,691 | $31K | 1/2/2026 | View on chart |
| AFCG | ▲ Buy | Grant | 5,474 | $15K | 11/20/2025 | View on chart |
| AGEN | ▲ Buy | Grant | 5,780 | $29K | 10/1/2025 | View on chart |
| AGEN | ▲ Buy | Grant | 7,401 | $26K | 7/1/2025 | View on chart |
| AGEN | ▲ Buy | Grant | 8,898 | $26K | 4/1/2025 | View on chart |
| AFCG | ▲ Buy | Grant | 1,792 | $15K | 2/25/2025 | View on chart |
| AFCG | ▲ Buy | Grant | 1,282 | $15K | 1/24/2024 | View on chart |
| AFCG | ▲ Buy | Grant | 963 | $15K | 1/3/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Agenus Fair Value Adjusted Following Trial Updates and Financing
Agenus saw its estimated fair value rise after recent trial updates and new financing activities. These developments provide context for the stock's current position within its 52-week range. The news highlights ongoing corporate actions that may influence how analysts view the company's future prospects.
Agenus Fair Value Adjusted Following Trial Updates and Financing. Agenus saw its estimated fair value rise after recent trial updates and new financing activities. These developments provide context for the stock's current position within its 52-week range. The news highlights ongoing corporate actions that may influence how analysts view the company's future prospects.